Clinical trial / 2010
Physiological doses of oral vitamin B12 significantly reduced plasma total homocysteine concentrations in Indians.
A cluster randomized trial evaluated the effect of physiological doses of oral vitamin B12 (2 or 10 µg) with or without 200 µg folic acid on plasma total homocysteine (tHcy) in 300 individuals over 12 months. At 12 months, tHcy reduced by a mean of 5.9 µmol/l in the 2 µg B12 group and 7.1 µmol/l in the 10 µg B12 group, compared to a non-significant rise of 1.2 µmol/l in the placebo group. The 2 µg and 10 µg B12 doses did not differ significantly from each other. In the 200 µg folic acid group, tHcy decreased by 4.8 µmol/l compared to 2.8 µmol/l in the folic acid placebo group, with no significant interaction between B12 and folic acid.
- Study type
- Cluster randomized, placebo-controlled, double-blind, 2x3 factorial trial
- Who was studied
- 300 individuals from 119 families in the Pune Maternal Nutrition Study in India
- What was measured
- Plasma total homocysteine (tHcy) concentration measured at baseline, 4, and 12 months
THE PAPER
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India.
Deshmukh US, Joglekar CV, Lubree HG, Ramdas LV, Bhat DS, Naik SS, Hardikar PS, Raut DA, Konde TB, Wills AK, Jackson AA, Refsum H, Nanivadekar AS, Fall CH, Yajnik CS. Eur J Clin Nutr, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.